This brand name is authorized in Canada, Israel, New Zealand, United States
The drug TUBERSOL contains one active pharmaceutical ingredient (API):
1
Tuberculin
UNII I7L8FKN87J - TUBERCULIN PURIFIED PROTEIN DERIVATIVE
|
Tuberculin PPD is indicated for the detection of a delayed hypersensitivity reaction to |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
TUBERSOL Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
V04CF01 | Tuberculin | V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CF Tuberculosis diagnostics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 00317268 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 6970 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 2238 |
Country: US | FDA, National Drug Code | Identifier(s): 49281-752, 50090-0261 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.